| |
|
|
|
Neu Base Therapeutics Inc  
|
|
3.8 0 (0%) |
09-16 16:00 |
|
Open: |
3.78 |
Pre close: |
3.8 |
Target:
|
4.79
|
|
High: |
3.91 |
Low: |
3.6438 |
Resistance:
|
4.10
4.79
|
|
Volume: |
52,422 |
Market Cap: |
124M |
Support:
|
3.58
3.26
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.80
 |
MACD |
MACD(12,26):
|
0.01  |
|
MA(20): |
3.79 |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
4.47 |
Stochastic Oscillator |
%K(14,3):
|
47.17 |
|
MA(250): |
6.76 |
%D(3): |
53.76 |
|
Average Volume(K) |
3-Month: |
19037
|
52-Week |
High:
|
12.89 |
|
10-Days: |
8753 |
Low: |
3.26 |
|
RSI |
RSI(14):
|
50.18 |
Change(%): |
-56.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.259 |
Return on Equity (ttm) |
-48.3 |
Shares Out. (M) |
32.72 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-28.5 |
Shares Float (M) |
26.61 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.33 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
32.91 |
|
Forward EPS |
-3.260 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
737 |
|
Book Value (p.s.) |
0.590 |
EBITDA (p.s.) |
-0.740 |
P/E |
-1.17 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
6.44 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-17.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-13.52 |
P/CF |
-7.31 |
|
|
|
|
|
|
